ReviewKorean circulation journal2019
KSHF Guidelines for the Management of Acute Heart Failure: Part II. Treatment of Acute Heart Failure.
Review in Korean circulation journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Treatment.International journal of heart failure · 2023Review
- Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Treatment.Korean circulation journal · 2023Review
- Development of Core Educational Content for Heart Failure Patients in Transition from Hospital to Home Care: A Delphi Study.International journal of environmental research and public health · 2022Article
- Physician adherence and patient-reported outcomes in heart failure with reduced ejection fraction in the era of angiotensin receptor-neprilysin inhibitor therapy.Scientific reports · 2022Article
- Myocardial strain to identify benefit from beta-blockers in patients with heart failure with reduced ejection fraction.ESC heart failure · 2022Observational
- Prognostic and Therapeutic Implications of Renal Insufficiency in Heart Failure.International journal of heart failure · 2022Review
- Prognostic impact of chromogranin A in patients with acute heart failure.Yeungnam University journal of medicine · 2021Article
- Heart Transplant Immunosuppression Strategies at Cedars-Sinai Medical Center.International journal of heart failure · 2021Review
- Heart Failure with Preserved Ejection Fraction: the Major Unmet Need in Cardiology.Korean circulation journal · 2020Review
- Cardiovascular Complications of Novel Anti-Cancer Immunotherapy: Old Problems from New Agents?Korean circulation journal · 2020Review
- Role of Cardiac Computed Tomography for Etiology Evaluation of Newly Diagnosed Heart Failure with Reduced Ejection Fraction.Journal of clinical medicine · 2020Article
- Is the use of RAS inhibitors safe in the current era of COVID-19 pandemic?Clinical hypertension · 2020Review
- Focused Update of 2016 Korean Society of Heart Failure Guidelines for the Management of Chronic Heart Failure.International journal of heart failure · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The prevalence of heart failure (HF) is on the rise due to the aging of society. Furthermore, the continuous progress and widespread adoption of screening and diagnostic strategies have led to an increase in the detection rate of HF, effectively increasing the number of patients requiring monitoring and treatment. Because HF is associated with substantial rates of mortality and morbidity, as well as high socioeconomic burden, there is an increasing need for developing specific guidelines for HF management. The Korean guidelines for the diagnosis and management of chronic HF were introduced in March 2016. However, chronic and acute HF represent distinct disease entities. Here, we introduce the Korean guidelines for the management of acute HF with reduced or preserved ejection fraction. Part II of this guideline covers the treatment of acute HF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.